🔗 Permalink

Inventor profile of:

Bronislava Gedulin

City:

Del Mar, California

Country:

United States

Published Applications:

Last publication date:

2025-09-11

Top Assignees for applications by Bronislava Gedulin

The entities that hold a legal rights for patent applications filed by inventor Gedulin Bronislava:

Satiogen Pharmaceuticals, Inc. 12 San Diego, CA United States
Amylin Pharmaceuticals, Inc. 8 San Diego, CA United States
SHIRE HUMAN GENETIC THERAPIES, INC. 6 Lexington, MA United States
Lumena Pharmaceuticals, Inc. 6 San Diego, CA United States
Lumena Pharmaceuticals LLC 3 Lexington, MA United States
Lumena Pharmaceuticals LLC 3 San Diego, CA United States
Amylin Pharmaceuticals, LLC 3 San Diego, CA United States
LUMENA PHARMACEUTIALS LLC 1 Lexington, MA United States
Lumena Pharmaceuticals, Inc. 1 Durham, NC United States
Astrazeneca Pharmaceuticals LP 1 Wilmington, DE United States

Recent patent applications by Gedulin Bronislava

Bronislava Gedulin from Del Mar, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11

US20250282808A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#2 | 2025-09-11

US20250281482A1

Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#3 | 2023-07-06

US20230212211A1

Human necessities

Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease

#4 | 2022-11-17

US20220362238A1

Human necessities

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

#5 | 2022-08-25

US20220265649A1

Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#6 | 2022-01-27

US20220023296A1

Human necessities

Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases

#7 | 2020-08-06

US20200246366A1

Human necessities

Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases

#8 | 2020-07-02

US20200207797A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#9 | 2020-03-05

US20200069715A1

Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#10 | 2019-08-15

US20190247390A1

Human necessities

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

#11 | 2019-06-06

US20190169217A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#12 | 2017-12-28

US20170368085A1

Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#13 | 2016-10-27

US20160310518A1

Human necessities

Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases

#14 | 2016-08-18

US20160235745A1

Human necessities

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

#15 | 2016-08-04

US20160220577A1

Human necessities

Bile acid recycling inhibitors for treatment of obesity and diabetes

#16 | 2015-04-30

US20150119345A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF GASTROINTESTINAL INFECTIONS

#17 | 2015-03-26

US20150087642A1

Chemistry; metallurgy

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

#18 | 2014-10-30

US20140323412A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#19 | 2014-09-18

US20140275090A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE

#20 | 2014-09-18

US20140271734A1

Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF BARRETT'S ESOPHAGUS AND GASTROESOPHAGEAL REFLUX DISEASE

#21 | 2014-08-28

US20140243281A1

Chemistry; metallurgy

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#22 | 2013-12-19

US20130338093A1

Human necessities

Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases

#23 | 2013-07-25

US20130190281A1

Human necessities

Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof

#24 | 2013-05-02

US20130109671A1

Human necessities

Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases

#25 | 2013-05-02

US20130108573A1

Human necessities

Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease

#26 | 2013-04-11

US20130090590A1

Human necessities

Methods and Apparatus for Treating Obesity and Diabetes

#27 | 2013-03-07

US20130059807A1

Human necessities

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

#28 | 2013-02-07

US20130034536A1

Human necessities

Bile Acid Recycling Inhibitors for Treatment of Pancreatitis

#29 | 2013-01-24

US20130023470A1

Human necessities

EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS

#30 | 2012-11-22

US20120295850A1

Human necessities

Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis

#31 | 2012-06-21

US20120157399A1

Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES

#32 | 2011-12-15

US20110306549A1

Human necessities

Methods of using GLP-1 receptor agonists to treat pancreatitis

#33 | 2011-12-01

US20110294767A1

Human necessities

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

#34 | 2011-06-23

US20110152204A1

Human necessities

Treatment of Obesity or Diabetes with Bile Acid Sequestrants

#35 | 2011-02-10

US20110034377A1

Human necessities

Exendin and exendin agonists for eating disorders

#36 | 2010-05-27

US20100130472A1

Human necessities

Bile acid recycling inhibitors for treatment of obesity and diabetes

#37 | 2010-05-27

US20100130426A1

Human necessities

Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

#38 | 2009-06-25

US20090163423A1

Chemistry; metallurgy

Exendins and exendin agonist analogs to regulate gastrointestinal motility

#39 | 2009-04-21

US10896244

Exendin pharmaceutical compositions

#40 | 2006-06-08

US20060122106A1

Physics

Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof

#41 | 2005-09-29

US20050215469A1

Human necessities

Pharmaceutical compositions containing exendins

#42 | 2005-03-31

US20050070472A1

Human necessities

Treatment of pancreatitis with amylin

#43 | 2005-02-24

US20050043238A1

Human necessities

Exendins and exendin agonists for weight reduction and obesity

InventorID:

54518 ⎘